Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Muehlenbachs, Atis ^a   Nabasumba, Carolyn ^b   McGready, Rose ^c,d,e   Turyakira, Eleanor ^b   Tumwebaze, Benon ^b   Dhorda, Mehul ^b   Nyehangane, Dan ^b   Nalusaji, Aisha ^b   Nosten, François ^c,d,e   Guerin, Philippe J ^b,e   Piola, Patrice ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b EPICENTRE   (France)

^c SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Artemether lumefantrine; Artemisinin based combination therapy; Falciparum; Haemozoin; Histology; Malaria in pregnancy; Pathology; Placental malaria; Quinine; Randomized controlled trial

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; HEMOGLOBIN; HEMOZOIN; QUININE;

ADULT; ARTICLE; BLOOD SMEAR; CALCULATION; CONTROLLED STUDY; DELIVERY; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HISTOLOGY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; NONHUMAN; OPEN STUDY; OUTCOME ASSESSMENT; PARASITE CLEARANCE; PARASITEMIA; PLACENTA; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY DISORDER; PRENATAL CARE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; REINFECTION; TREATMENT DURATION; UGANDA;

ADULT; ANTIMALARIALS; ARTEMISININS; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; HEMEPROTEINS; HISTOCYTOCHEMISTRY; HUMANS; INFANT, NEWBORN; MALARIA, FALCIPARUM; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; QUININE; TREATMENT OUTCOME; UGANDA; YOUNG ADULT;

EID: 84860376953     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-150     Document Type: Article

References (43)

1. Epidemiology and burden of malaria in pregnancy. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD, Lancet Infect Dis 2007 7 93 104 10.1016/S1473-3099(07)70021-X 17251080 (Pubitemid 46123132)
2. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Dondorp A, Nosten F, Stepniewska K, Day N, White N, Lancet 2005 366 717 725 16125588 (Pubitemid 41207233)
3. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, et al. Lancet 2010 376 1647 1657 10.1016/S0140- 6736(10)61924-1 21062666
4. WHO, Guidelines for the treatment of malaria World Health Organization, Geneva 2 2010
5. Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. McGready R, Cho T, Samuel, Villegas L, Brockman A, van Vugt M, Looareesuwan S, White NJ, Nosten F, Trans R Soc Trop Med Hyg 2001 95 651 656 10.1016/S0035-9203(01)90106-3 11816439 (Pubitemid 34202258)
6. Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy. McGready R, Brockman A, Cho T, Cho D, van Vugt M, Luxemburger C, Chongsuphajaisiddhi T, White NJ, Nosten F, Trans R Soc Trop Med Hyg 2000 94 689 693 10.1016/S0035-9203(00)90235-9 11198658
7. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated Plasmodium falciparum treatment in pregnancy. McGready R, Tan SO, Ashley EA, Pimanpanarak M, Viladpai-Nguen J, Phaiphun L, Wustefeld K, Barends M, Laochan N, Keereecharoen L, et al. PLoS Med 2008 5 253 10.1371/journal.pmed.0050253 19265453
8. Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum. McGready R, Cho T, Keo NK, Thwai KL, Villegas L, Looareesuwan S, White NJ, Nosten F, Clin Infect Dis 2001 33 2009 2016 10.1086/324349 11712093 (Pubitemid 33152395)
9. Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial. Piola P, Nabasumba C, Turyakira E, Dhorda M, Lindegardh N, Nyehangane D, Snounou G, Ashley EA, McGready R, Nosten F, Gurin PJ, Lancet Infect Dis 2010 10 762 769 10.1016/S1473-3099(10)70202-4 20932805
10. Artesunate plus sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria during pregnancy in eastern Sudan. Adam I, Ali DM, Abdalla MA, Trans R Soc Trop Med Hyg 2006 100 632 635 10.1016/j.trstmh.2005.09.019 16436287
11. Randomized trial of artesunate+amodiaquine, sulfadoxine- pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania. Mutabingwa TK, Muze K, Ord R, Briceno M, Greenwood BM, Drakeley C, Whitty CJ, PLoS One 2009 4 5138 10.1371/journal.pone.0005138 19352498
12. A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women. Kalilani L, Mofolo I, Chaponda M, Rogerson SJ, Alker AP, Kwiek JJ, Meshnick SR, PLoS One 2007 2 1166 10.1371/journal.pone.0001166 18000538 (Pubitemid 351637964)
13. Compliance with artesunate and quinine + tetracycline treatment of uncomplicated falciparum malaria in Thailand. Fungladda W, Honrado ER, Thimasarn K, Kitayaporn D, Karbwang J, Kamolratanakul P, Masngammueng R, Bull World Health Organ 1998 76 Suppl 1 59 66 9763724 (Pubitemid 128685315)
14. Effectiveness of quinine monotherapy for the treatment of Plasmodium falciparum infection in pregnant women in Lambarene, Gabon. Adegnika AA, Breitling LP, Agnandji ST, Chai SK, Schutte D, Oyakhirome S, Schwarz NG, Grobusch MP, Missinou MA, Ramharter M, Issifou S, Kremsner PG, AmJTrop Med Hyg 2005 73 263 266 (Pubitemid 41278694)
15. World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs. Price RN, Dorsey G, Ashley EA, Barnes KI, Baird JK, dAlessandro U, Guerin PJ, Laufer MK, Naidoo I, Nosten F, 1liaro P, Plowe CV, Ringwald P, Sibley CH, Stepniewska K, White NJ, Malar J 2007 6 119 10.1186/1475-2875-6-119 17822532 (Pubitemid 47561493)
16. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. Lau GK, Piratvisuth T, Luo KX, Marcellin P, Thongsawat S, Cooksley G, Gane E, Fried MW, Chow WC, Paik SW, Chang WY, Berg T, Flisiak R, McCloud P, Pluck N, Peginterferon Alfa-2a HBeAg-Positive Chronic Hepatitis B Study Group, N Engl J Med 2005 352 2682 2695 10.1056/NEJMoa043470 15987917 (Pubitemid 41007823)
17. Alemtuzumab induction in renal transplantation. Hanaway MJ, Woodle ES, Mulgaonkar S, Peddi VR, Kaufman DB, First MR, Croy R, Holman J, N Engl J Med 2011 364 1909 1919 10.1056/NEJMoa1009546 21591943
18. Response rates, survival, and chemotherapy trials. Pazdur R, J Natl Cancer Inst 2000 92 1552 1553 10.1093/jnci/92.19.1552 11018082
19. A novel histological grading scheme for placental malaria applied in areas of high and low malaria transmission. Muehlenbachs A, Fried M, McGready R, Harrington WE, Mutabingwa TK, Nosten F, Duffy PE, J Infect Dis 2010 202 1608 1616 10.1086/656723 20929353
20. The impact of placental malaria on gestational age and birth weight. Menendez C, Ordi J, Ismail MR, Ventura PJ, Aponte JJ, Kahigwa E, Font F, Alonso PL, J Infect Dis 2000 181 1740 1745 10.1086/315449 10823776 (Pubitemid 30387768)
21. Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae. Shulman CE, Marshall T, Dorman EK, Bulmer JN, Cutts F, Peshu N, Marsh K, Trop Med Int Health 2001 6 770 778 10.1046/j.1365-3156.2001.00786.x 11679125 (Pubitemid 32989630)
22. Malaria chemoprophylaxis, infection of the placenta and birth weight in Gambian primigravidae. Menendez C, Todd J, Alonso PL, Lulat S, Francis N, Greenwood BM, J Trop Med Hyg 1994 97 244 248 8064949 (Pubitemid 24247372)
23. A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. Menendez C, Bardaji A, Sigauque B, Romagosa C, Sanz S, Serra-Casas E, Macete E, Berenguera A, David C, Dobano C, Naniche D, Mayor A, Ordi J, Mandomando I, Aponte JJ, Mabunda S, Alonso PL, PLoS One 2008 3 1934 10.1371/journal.pone.0001934 18398460 (Pubitemid 351984114)
24. Maternal vitamin A supplementation and immunity to malaria in pregnancy in Ghanaian primigravids. Cox SE, Staalsoe T, Arthur P, Bulmer JN, Tagbor H, Hviid L, Frost C, Riley EM, Kirkwood BR, Trop Med Int Health 2005 10 1286 1297 10.1111/j.1365-3156.2005.01515.x 16359410 (Pubitemid 41789683)
25. Malaria chemosuppression in pregnancy. V. Placenta malarial changes among three different prophylaxis groups. Mutabingwa TK, Eling WM, Kitinya JN, Malle LN, de Geus A, Trop Geogr Med 1993 45 274 279 8116057 (Pubitemid 24021553)
26. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women. Hamer DH, Mwanakasale V, Macleod WB, Chalwe V, Mukwamataba D, Champo D, Mwananyanda L, Chilengi R, Mubikayi L, Mulele CK, et al. J Infect Dis 2007 196 1585 1594 10.1086/522142 18008241 (Pubitemid 351411955)
27. Placental malaria. I. Pathological classification. Bulmer JN, Rasheed FN, Francis N, Morrison L, Greenwood BM, Histopathology 1993 22 211 218 10.1111/j.1365-2559.1993.tb00110.x 8495954 (Pubitemid 23105129)
28. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. White NJ, Antimicrob Agents Chemother 1997 41 1413 1422 9210658 (Pubitemid 27289660)
29. Heterogeneous decrease in malaria prevalence in children over a six-year period in south-western Uganda. De Beaudrap P, Nabasumba C, Grandesso F, Turyakira E, Schramm B, Boum Y, Etard JF, Malar J 2011 10 132 10.1186/1475-2875-10-132 21592332
30. The effect of maternal anaemia and iron deficiency on the ratio of fetal weight to placental weight. Godfrey KM, Redman CW, Barker DJ, Osmond C, Br J Obstet Gynaecol 1991 98 886 891 10.1111/j.1471-0528.1991.tb13510.x 1911607
31. Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes. Fried M, Muga RO, Misore AO, Duffy PE, J Immunol 1998 160 2523 2530 9498798 (Pubitemid 28119939)
32. Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria. Suguitan AL, Leke RG, Fouda G, Zhou A, Thuita L, Metenou S, Fogako J, Megnekou R, Taylor DW, J Infect Dis 2003 188 1074 1082 10.1086/378500 14513430 (Pubitemid 37268260)
33. Malarial pigment (haemozoin): a very active inert substance. Arese P, Schwarzer E, Ann Trop Med Parasitol 1997 91 501 516 10.1080/00034989760879 9329987 (Pubitemid 27367587)
34. The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission. McGready R, Davison BB, Stepniewska K, Cho T, Shee H, Brockman A, Udomsangpetch R, Looareesuwan S, White NJ, Meshnick SR, Nosten F, Am J Trop Med Hyg 2004 70 398 407 15100454 (Pubitemid 38525553)
35. HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya. van Eijk AM, Ayisi JG, ter Kuile FO, Misore AO, Otieno JA, Rosen DH, Kager PA, Steketee RW, Nahlen BL, AIDS 2003 17 595 603 10.1097/00002030- 200303070-00015 12598780 (Pubitemid 36293113)
36. Impairment of a pregnant womans acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Steketee RW, Wirima JJ, Bloland PB, Chilima B, Mermin JH, Chitsulo L, Breman JG, AmJTrop Med Hyg 1996 55 42 49
37. Effectiveness of nevirapine and zidovudine in a pilot program for the prevention of mother-to-child transmission of HIV-1 in Uganda. Bajunirwe F, Massaquoi I, Asiimwe S, Kamya MR, Arts EJ, Whalen CC, Afr Health Sci 2004 4 146 154 15687066
38. The parasite clearance curve. White NJ, Malar J 2011 10 278 10.1186/1475-2875-10-278 21939506
39. Effect of malaria on placental volume measured using three-dimensional ultrasound: a pilot study. Rijken MJ, Moroski WE, Kiricharoen S, Karunkonkowit N, Stevenson G, Ohuma EO, Noble JA, Kennedy SH, McGready R, Papageorghiou AT, Nosten FH, Malar J 2012 11 5 10.1186/1475-2875-11-5 22222152
40. Placental haemozoin and malaria in pregnancy. Sullivan AD, Nyirenda T, Cullinan T, Taylor T, Lau A, Meshnick SR, Placenta 2000 21 417 421 10.1053/plac.1999.0479 10833379 (Pubitemid 30364878)
41. Haemozoin as a marker of placental parasitization. McGready R, Brockman A, Cho T, Levesque MA, Tkachuk AN, Meshnick SR, Nosten F, Trans R Soc Trop Med Hyg 2002 96 644 646 10.1016/S0035-9203(02)90339-1 12625141 (Pubitemid 36231487)
42. Pathology services in developing countries: a challenge. Benediktsson H, Whitelaw J, Roy I, Arch Pathol Lab Med 2007 131 1636 1639 17979479 (Pubitemid 350077458)
43. www.mr4.org